Global Anti Obesity Drugs Market Professional Survey Report 2016

November 2016 | 111 pages | ID: G4991BCA657EN
QYResearch

Abstracts

Notes:

Production, means the output of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies Anti Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Merck
• Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

By types, the market can be split into

• Type I
• Type II
• Type III

By Application, the market can be split into

• Application 1
• Application 2
• Application 3

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Anti Obesity Drugs Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF ANTI OBESITY DRUGS

1.1 Definition and Specifications of Anti Obesity Drugs
  1.1.1 Definition of Anti Obesity Drugs
  1.1.2 Specifications of Anti Obesity Drugs
1.2 Classification of Anti Obesity Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Anti Obesity Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTI OBESITY DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anti Obesity Drugs
2.3 Manufacturing Process Analysis of Anti Obesity Drugs
2.4 Industry Chain Structure of Anti Obesity Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTI OBESITY DRUGS

3.1 Capacity and Commercial Production Date of Global Anti Obesity Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Anti Obesity Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Anti Obesity Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Anti Obesity Drugs Major Manufacturers in 2015

4 GLOBAL ANTI OBESITY DRUGS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Anti Obesity Drugs Capacity and Growth Rate Analysis
  4.2.2 2015 Anti Obesity Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Anti Obesity Drugs Sales and Growth Rate Analysis
  4.3.2 2015 Anti Obesity Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Anti Obesity Drugs Sales Price
  4.4.2 2015 Anti Obesity Drugs Sales Price Analysis (Company Segment)

5 ANTI OBESITY DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Anti Obesity Drugs Market Analysis
  5.1.1 North America Anti Obesity Drugs Market Overview
  5.1.2 North America 2011-2016E Anti Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Anti Obesity Drugs Sales Price Analysis
  5.1.4 North America 2015 Anti Obesity Drugs Market Share Analysis
5.2 China Anti Obesity Drugs Market Analysis
  5.2.1 China Anti Obesity Drugs Market Overview
  5.2.2 China 2011-2016E Anti Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Anti Obesity Drugs Sales Price Analysis
  5.2.4 China 2015 Anti Obesity Drugs Market Share Analysis
5.3 Europe Anti Obesity Drugs Market Analysis
  5.3.1 Europe Anti Obesity Drugs Market Overview
  5.3.2 Europe 2011-2016E Anti Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016E Anti Obesity Drugs Sales Price Analysis
  5.3.4 Europe 2015 Anti Obesity Drugs Market Share Analysis
5.4 Southeast Asia Anti Obesity Drugs Market Analysis
  5.4.1 Southeast Asia Anti Obesity Drugs Market Overview
  5.4.2 Southeast Asia 2011-2016E Anti Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016E Anti Obesity Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2015 Anti Obesity Drugs Market Share Analysis
5.5 Japan Anti Obesity Drugs Market Analysis
  5.5.1 Japan Anti Obesity Drugs Market Overview
  5.5.2 Japan 2011-2016E Anti Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016E Anti Obesity Drugs Sales Price Analysis
  5.5.4 Japan 2015 Anti Obesity Drugs Market Share Analysis
5.6 India Anti Obesity Drugs Market Analysis
  5.6.1 India Anti Obesity Drugs Market Overview
  5.6.2 India 2011-2016E Anti Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Anti Obesity Drugs Sales Price Analysis
  5.6.4 India 2015 Anti Obesity Drugs Market Share Analysis

6 GLOBAL 2011-2016E ANTI OBESITY DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Anti Obesity Drugs Sales by Type
6.2 Different Types of Anti Obesity Drugs Product Interview Price Analysis
6.3 Different Types of Anti Obesity Drugs Product Driving Factors Analysis
  6.3.1 Type I Anti Obesity Drugs Growth Driving Factor Analysis
  6.3.2 Type II Anti Obesity Drugs Growth Driving Factor Analysis
  6.3.3 Type III Anti Obesity Drugs Growth Driving Factor Analysis

7 GLOBAL 2011-2016E ANTI OBESITY DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Anti Obesity Drugs Consumption by Application
7.2 Different Application of Anti Obesity Drugs Product Interview Price Analysis
7.3 Different Application of Anti Obesity Drugs Product Driving Factors Analysis
  7.3.1 Application 1 Anti Obesity Drugs Growth Driving Factor Analysis
  7.3.2 Application 2 Anti Obesity Drugs Growth Driving Factor Analysis
  7.3.3 Application 3 Anti Obesity Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTI OBESITY DRUGS

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 Pfizer 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.2 Merck
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 Merck 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Merck 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.3 Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Roche 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.4 GlaxoSmithKline
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 GlaxoSmithKline 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 GlaxoSmithKline 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.5 AstraZeneca
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 AstraZeneca 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 AstraZeneca 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.6 Boehringer Ingelheim
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Boehringer Ingelheim 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Boehringer Ingelheim 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.7 Novo Nordisk
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Novo Nordisk 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novo Nordisk 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.8 Eisai
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Eisai 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Eisai 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.9 Norgine
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 Norgine 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Norgine 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.10 Arena Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Arena Pharmaceuticals 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Arena Pharmaceuticals 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.11 Orexigen Therapeutics
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
    8.11.2.1 Type I
    8.11.2.2 Type II
    8.11.2.3 Type III
  8.11.3 Orexigen Therapeutics 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Orexigen Therapeutics 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.12 Vivus
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
    8.12.2.1 Type I
    8.12.2.2 Type II
    8.12.2.3 Type III
  8.12.3 Vivus 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Vivus 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.13 Alizyme
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
    8.13.2.1 Type I
    8.13.2.2 Type II
    8.13.2.3 Type III
  8.13.3 Alizyme 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Alizyme 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.14 Rhythm Pharmaceuticals
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
    8.14.2.1 Type I
    8.14.2.2 Type II
    8.14.2.3 Type III
  8.14.3 Rhythm Pharmaceuticals 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 Rhythm Pharmaceuticals 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.15 Shionogi
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
    8.15.2.1 Type I
    8.15.2.2 Type II
    8.15.2.3 Type III
  8.15.3 Shionogi 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Shionogi 2015 Anti Obesity Drugs Business Region Distribution Analysis
8.16 Zafgan
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
    8.16.2.1 Type I
    8.16.2.2 Type II
    8.16.2.3 Type III
  8.16.3 Zafgan 2015 Anti Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.16.4 Zafgan 2015 Anti Obesity Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ANTI OBESITY DRUGS MARKET

9.1 Global Anti Obesity Drugs Market Trend Analysis
  9.1.1 Global 2016-2021 Anti Obesity Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Anti Obesity Drugs Sales Price Forecast
9.2 Anti Obesity Drugs Regional Market Trend
  9.2.1 North America 2016-2021 Anti Obesity Drugs Consumption Forecast
  9.2.2 China 2016-2021 Anti Obesity Drugs Consumption Forecast
  9.2.3 Europe 2016-2021 Anti Obesity Drugs Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Anti Obesity Drugs Consumption Forecast
  9.2.5 Japan 2016-2021 Anti Obesity Drugs Consumption Forecast
  9.2.6 India 2016-2021 Anti Obesity Drugs Consumption Forecast
9.3 Anti Obesity Drugs Market Trend (Product Type)
9.4 Anti Obesity Drugs Market Trend (Application)

10 ANTI OBESITY DRUGS MARKETING TYPE ANALYSIS

10.1 Anti Obesity Drugs Regional Marketing Type Analysis
10.2 Anti Obesity Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Anti Obesity Drugs by Regions
10.4 Anti Obesity Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTI OBESITY DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ANTI OBESITY DRUGS MARKET PROFESSIONAL SURVEY REPORT 2016

Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti Obesity Drugs
Table Product Specifications of Anti Obesity Drugs
Table Classification of Anti Obesity Drugs
Figure Global Production Market Share of Anti Obesity Drugs by Type in 2015
Table Applications of Anti Obesity Drugs
Figure Global Consumption Volume Market Share of Anti Obesity Drugs by Application in 2015
Figure Market Share of Anti Obesity Drugs by Regions
Figure North America Anti Obesity Drugs Market Size (2011-2021)
Figure China Anti Obesity Drugs Market Size (2011-2021)
Figure Europe Anti Obesity Drugs Market Size (2011-2021)
Figure Southeast Asia Anti Obesity Drugs Market Size (2011-2021)
Figure Japan Anti Obesity Drugs Market Size (2011-2021)
Figure India Anti Obesity Drugs Market Size (2011-2021)
Table Anti Obesity Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Anti Obesity Drugs in 2015
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Industry Chain Structure of Anti Obesity Drugs
Table Capacity (K MT) and Commercial Production Date of Global Anti Obesity Drugs Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Anti Obesity Drugs Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Anti Obesity Drugs Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Anti Obesity Drugs Major Manufacturers in 2015
Table Global Capacity (K MT), Sales (K MT), Price (USD/MT), Cost (USD/MT), Sales Revenue (M USD) and Gross Margin of Anti Obesity Drugs 2011-2016
Figure Global 2011-2016E Anti Obesity Drugs Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Anti Obesity Drugs Market Size (Value) and Growth Rate
Table 2011-2016E Global Anti Obesity Drugs Capacity and Growth Rate
Table 2015 Global Anti Obesity Drugs Capacity List (Company Segment)
Table 2011-2016E Global Anti Obesity Drugs Sales and Growth Rate
Table 2015 Global Anti Obesity Drugs Sales List (Company Segment)
Table 2011-2016E Global Anti Obesity Drugs Sales Price
Table 2015 Global Anti Obesity Drugs Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Anti Obesity Drugs 2011-2016 (K MT)
Figure North America 2011-2016E Anti Obesity Drugs Sales Price (USD/MT)
Figure North America 2015 Anti Obesity Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Anti Obesity Drugs 2011-2016 (K MT)
Figure China 2011-2016E Anti Obesity Drugs Sales Price (USD/MT)
Figure China 2015 Anti Obesity Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Anti Obesity Drugs 2011-2016 (K MT)
Figure Europe 2011-2016E Anti Obesity Drugs Sales Price (USD/MT)
Figure Europe 2015 Anti Obesity Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Anti Obesity Drugs 2011-2016 (K MT)
Figure Southeast Asia 2011-2016E Anti Obesity Drugs Sales Price (USD/MT)
Figure Southeast Asia 2015 Anti Obesity Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Anti Obesity Drugs 2011-2016 (K MT)
Figure Japan 2011-2016E Anti Obesity Drugs Sales Price (USD/MT)
Figure Japan 2015 Anti Obesity Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Anti Obesity Drugs 2011-2016 (K MT)
Figure India 2011-2016E Anti Obesity Drugs Sales Price (USD/MT)
Figure India 2015 Anti Obesity Drugs Sales Market Share
Table Global 2011-2016E Anti Obesity Drugs Sales by Type
Table Different Types Anti Obesity Drugs Product Interview Price
Table Global 2011-2016E Anti Obesity Drugs Sales by Application
Table Different Application Anti Obesity Drugs Product Interview Price
Table Pfizer Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Pfizer Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Anti Obesity Drugs Business Region Distribution
Table Merck Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Merck Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Merck 2015 Anti Obesity Drugs Business Region Distribution
Table Roche Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Roche Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Anti Obesity Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 GlaxoSmithKline Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 GlaxoSmithKline 2015 Anti Obesity Drugs Business Region Distribution
Table AstraZeneca Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 AstraZeneca Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 AstraZeneca 2015 Anti Obesity Drugs Business Region Distribution
Table Boehringer Ingelheim Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Boehringer Ingelheim Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Boehringer Ingelheim 2015 Anti Obesity Drugs Business Region Distribution
Table Novo Nordisk Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Novo Nordisk Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Novo Nordisk 2015 Anti Obesity Drugs Business Region Distribution
Table Eisai Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Eisai Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Eisai 2015 Anti Obesity Drugs Business Region Distribution
Table Norgine Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Norgine Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Norgine 2015 Anti Obesity Drugs Business Region Distribution
Table Arena Pharmaceuticals Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Arena Pharmaceuticals Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Arena Pharmaceuticals 2015 Anti Obesity Drugs Business Region Distribution
Table Orexigen Therapeutics Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Orexigen Therapeutics Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Orexigen Therapeutics 2015 Anti Obesity Drugs Business Region Distribution
Table Vivus Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Vivus Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Vivus 2015 Anti Obesity Drugs Business Region Distribution
Table Alizyme Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Alizyme Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Alizyme 2015 Anti Obesity Drugs Business Region Distribution
Table Rhythm Pharmaceuticals Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Rhythm Pharmaceuticals Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Rhythm Pharmaceuticals 2015 Anti Obesity Drugs Business Region Distribution
Table Shionogi Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Shionogi Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Shionogi 2015 Anti Obesity Drugs Business Region Distribution
Table Zafgan Information List
Table Type I Anti Obesity Drugs Overview
Table Type II Anti Obesity Drugs Overview
Table Type III Anti Obesity Drugs Overview
Table 2015 Zafgan Anti Obesity Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Zafgan 2015 Anti Obesity Drugs Business Region Distribution
Figure Global 2016-2021 Anti Obesity Drugs Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Anti Obesity Drugs Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Anti Obesity Drugs Sales Price (USD/MT) Forecast
Figure North America 2016-2021 Anti Obesity Drugs Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Anti Obesity Drugs Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Anti Obesity Drugs Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Anti Obesity Drugs Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Anti Obesity Drugs Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Anti Obesity Drugs Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K MT) of Anti Obesity Drugs by Types 2016-2021
Table Global Consumption Volume (K MT) of Anti Obesity Drugs by Applications 2016-2021
Table Traders or Distributors with Contact Information of Anti Obesity Drugs by Regions
Table Part of Interviewees Record List